[1] |
KAPLAN MM, GERSHWIN ME. Primary biliary cirrhosis[J]. N Engl J Med, 2005, 353(12): 1261-1273. DOI: 10.1056/NEJMra043898.
|
[2] |
EFE C, TORGUTALP M, HENRIKSSON I, et al. Extrahepatic autoimmune diseases in primary biliary cholangitis: prevalence and significance for clinical presentation and disease outcome[J]. J Gastroenterol Hepatol, 2021, 36(4): 936-942. DOI: 10.1111/jgh.15214.
|
[3] |
CHEN S, LI MQ, DUAN WJ, et al. Concomitant extrahepatic autoimmune diseases do not compromise the long-term outcomes of primary biliary cholangitis[J]. Hepatobiliary Pancreat Dis Int, 2022, 21(6): 577-582. DOI: 10.1016/j.hbpd.2022.05.009.
|
[4] |
WATT FE, JAMES OF, JONES DE. Patterns of autoimmunity in primary biliary cirrhosis patients and their families: a population-based cohort study[J]. QJM, 2004, 97(7): 397-406. DOI: 10.1093/qjmed/hch078.
|
[5] |
PANZER S, PENNER E, NELSON PJ, et al. Identification of the platelet glycoprotein IIb/IIIa complex as a target antigen in primary biliary cirrhosis-associated autoimmune thrombocytopenia. Evidence that platelet-reactive autoantibodies can also bind to the mitochondrial antigen M2[J]. J Autoimmun, 1990, 3(4): 473-483. DOI: 10.1016/s0896-8411(05)80014-9.
|
[6] |
KUWANA M, KABURAKI J, PANDEY JP, et al. HLA class Ⅱ alleles in Japanese patients with immune thrombocytopenic purpura. Associations with anti-platelet glycoprotein autoantibodies and responses to splenectomy[J]. Tissue Antigens, 2000, 56(4): 337-343. DOI: 10.1034/j.1399-0039.2000.560405.x.
|
[7] |
TANAKA A, LEUNG P, GERSHWIN ME. The genetics of primary biliary cholangitis[J]. Curr Opin Gastroenterol, 2019, 35(2): 93-98. DOI: 10.1097/MOG.0000000000000507.
|
[8] |
LI Y, LIU X, WANG Y, et al. Novel HLA-DRB1 alleles contribute risk for disease susceptibility in primary biliary cholangitis[J]. Dig Liver Dis, 2022, 54(2): 228-236. DOI: 10.1016/j.dld.2021.04.010.
|
[9] |
MA WY, DENG ZH. Current status of immunogenetic studies on primary biliary cholangitis[J]. J Clin Hepatol, 2020, 36(4): 932-935. DOI: 10.3969/j.issn.1001-5256.2020.04.050.
马伟煜, 邓志华. 原发性胆汁性胆管炎的免疫遗传研究现状[J]. 临床肝胆病杂志, 2020, 36(4): 932-935. DOI: 10.3969/j.issn.1001-5256.2020.04.050.
|
[10] |
NEUNERT C, TERRELL DR, ARNOLD DM, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia[J]. Blood Adv. 2019. 3(23): 3829-3866. DOI: 10.1182/bloodadvances.2019000966.
|
[11] |
Chinese Society of Hepatology, Chinese Medical Association. Guidelines on the diagnosis and management of primary biliary cholangitis (2021)[J]. J Clin Hepatol, 2022, 38(1): 35-41. DOI: 10.3760/cma.j.cn112138-20211112-00794.
|